Brent Van Rite, Ph.D. - Publications

Affiliations: 
2012 College of Engineering University of Oklahoma, Norman, OK, United States 
Area:
Biomedical Engineering, Oncology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Investigation. 31: 505-10. PMID 24083814 DOI: 10.3109/07357907.2013.840383  0.672
2013 Neves LF, Krais JJ, Van Rite BD, Ramesh R, Resasco DE, Harrison RG. Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology. 24: 375104. PMID 23975064 DOI: 10.1088/0957-4484/24/37/375104  0.646
2013 Krais J, Van Rite B, Kurkjian C, Harrison R. Evaluation of three vascular-targeted enzyme prodrug systems for breast cancer therapy Food, Pharmaceutical and Bioengineering Division 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 223.  0.554
2011 Prickett WM, Van Rite BD, Resasco DE, Harrison RG. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 22: 455101. PMID 21993223 DOI: 10.1088/0957-4484/22/45/455101  0.683
2011 Van Rite BD, Harrison RG. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Letters. 307: 53-61. PMID 21546157 DOI: 10.1016/j.canlet.2011.03.016  0.746
2011 Van Rite BD, Lazrak YA, Pagnon ML, Palwai NR, Neves LF, McFetridge PS, Harrison RG. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Letters. 301: 177-84. PMID 21194833 DOI: 10.1016/J.Canlet.2010.11.013  0.346
Show low-probability matches.